Esaulenko E - Search Results

Year	Number of Results
1989	1
1991	1
2002	1
2006	1
2007	2
2010	2
2011	2
2013	3
2014	1
2015	6
2017	1
2018	1
2021	1
2022	2
2023	3
2024	3
2025	0

1

[A new approach to etiotropic therapy ARVI in children].

Sabitov AU, Kovtun OP, Esaulenko EV, Sorokin PV. Sabitov AU, et al. Among authors: esaulenko ev. Ter Arkh. 2022 Dec 26;94(11):1278-1284. doi: 10.26442/00403660.2022.11.201979. Ter Arkh. 2022. PMID: 37167166 Russian.

2

[Clinical and morphological correlations in occult hepatitis B].

Zinserling VA, Esaulenko EV, Karev VE, Bubochkin AB, Sukhoruk AA, Shibaeva EO, Ponyatishina MV. Zinserling VA, et al. Among authors: esaulenko ev. Arkh Patol. 2017;79(6):8-13. doi: 10.17116/patol20177968-13. Arkh Patol. 2017. PMID: 29265072 Russian.

3

[Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].

Boumbaly S, Balde TAL, Semenov AV, Ostankova YV, Serikova EN, Naidenova EV, Valutite DE, Shchemelev AN, Zueva EB, Esaulenko EV, Totolian AA. Boumbaly S, et al. Among authors: esaulenko ev. Vopr Virusol. 2022 Mar 15;67(1):59-68. doi: 10.36233/0507-4088-92. Vopr Virusol. 2022. PMID: 35293189 Russian.

4

Prevalence of HIV and Viral Hepatitis Markers among Healthcare Workers in the Republic of Guinea.

Ostankova YV, Shchemelev AN, Boumbaly S, Balde TAL, Zueva EB, Valutite DE, Serikova EN, Davydenko VS, Skvoroda VV, Vasileva DA, Semenov AV, Esaulenko EV, Totolian AA. Ostankova YV, et al. Among authors: esaulenko ev. Diagnostics (Basel). 2023 Jan 19;13(3):378. doi: 10.3390/diagnostics13030378. Diagnostics (Basel). 2023. PMID: 36766482 Free PMC article.

5

CX3CL1/Fractalkine: A Potential Biomarker for Liver Fibrosis in Chronic HBV Infection.

Arsentieva NA, Korobova ZR, Batsunov OK, Lyubimova NE, Basina VV, Esaulenko EV, Totolian AA. Arsentieva NA, et al. Among authors: esaulenko ev. Curr Issues Mol Biol. 2024 Sep 10;46(9):9948-9957. doi: 10.3390/cimb46090593. Curr Issues Mol Biol. 2024. PMID: 39329945 Free PMC article.

6

Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation.

Esaulenko EV, Yakovlev AA, Volkov GA, Sukhoruk AA, Surkov KG, Kruglyakov PV, Diaz-Mitoma F. Esaulenko EV, et al. Clin Infect Dis. 2021 Nov 2;73(9):e3333-e3339. doi: 10.1093/cid/ciaa1649. Clin Infect Dis. 2021. PMID: 33119068 Free PMC article. Clinical Trial.

7

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Zeuzem S, Flisiak R, Vierling JM, Mazur W, Mazzella G, Thongsawat S, Abdurakhmanov D, Van Kính N, Calistru P, Heo J, Stanciu C, Gould M, Makara M, Hsu SJ, Buggisch P, Samuel D, Mutimer D, Nault B, Merz M, Bao W, Griffel LH, Brass C, Naoumov NV; ESSENTIAL II Study Group. Zeuzem S, et al. Aliment Pharmacol Ther. 2015 Oct;42(7):829-44. doi: 10.1111/apt.13342. Epub 2015 Aug 4. Aliment Pharmacol Ther. 2015. PMID: 26238707 Clinical Trial.

8

[Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial].

Kalyuzhin OV, Gorelov AV, Malyavin AG, Zaytsev AA, Esaulenko EV, Novak KE, Bykov AS. Kalyuzhin OV, et al. Among authors: esaulenko ev. Ter Arkh. 2023 Nov 23;95(10):850-858. doi: 10.26442/00403660.2023.10.202464. Ter Arkh. 2023. PMID: 38159017 Clinical Trial. Russian.

9

[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19].

Sabitov AU, Lioznov DA, Zhdanov KV, Tikhonova EP, Esaulenko EV, Kovtun OP, Kuznetsov PL, Sorokin PV. Sabitov AU, et al. Among authors: esaulenko ev. Ter Arkh. 2024 Jun 3;96(5):517-522. doi: 10.26442/00403660.2024.05.202770. Ter Arkh. 2024. PMID: 38829814 Clinical Trial. Russian.

10

[Frequency of drug resistance and immune escape mutations in the hepatitis B virus genome detected in pregnant women in the Republic of Guinea].

Balde T, Ostankova YV, Boumbaly S, Naidenova EV, Zueva EB, Serikova EN, Valutite DE, Schemelev AN, Davydenko VS, Esaulenko EV, Totolian AA. Balde T, et al. Among authors: esaulenko ev. Vopr Virusol. 2023 Jul 6;68(3):228-241. doi: 10.36233/0507-4088-175. Vopr Virusol. 2023. PMID: 37436414 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year